Molecular pathological predictive diagnostics in a patient with non-small cell lung cancer treated with crizotinib therapy: A case report
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10366252" target="_blank" >RIV/00216208:11110/17:10366252 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11130/17:10366252 RIV/00064203:_____/17:10366252 RIV/00023884:_____/12:00007552 RIV/00064165:_____/17:10366252
Result on the web
<a href="http://dx.doi.org/10.3892/ol.2017.7167" target="_blank" >http://dx.doi.org/10.3892/ol.2017.7167</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3892/ol.2017.7167" target="_blank" >10.3892/ol.2017.7167</a>
Alternative languages
Result language
angličtina
Original language name
Molecular pathological predictive diagnostics in a patient with non-small cell lung cancer treated with crizotinib therapy: A case report
Original language description
Lung cancer is one of the most common malignant cancers in the Czech Republic in men, with the highest mortality rate of all the malignant diseases. The development of biological treatment enables study into novel personalized treatment options. This type of treatment is usually of high quality, and is often demanding of predictive and biopsy diagnostics, which is dependent on the quality of the collected material and close cooperation among particular departments. The present study describes the complete biopsy and predictive examinations performed in a male patient with lung adenocarcinoma, with an emphasis on the logistics of the whole process and the application of the tyrosine kinase inhibitors, crizotinib and LDK378. The patient experienced a long overall survival time of 28 months from diagnosis.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
<a href="/en/project/NV15-28188A" target="_blank" >NV15-28188A: Monitoring Cancer Microenvironment and Immune response in Adjudicating the Prognosis and therapy response in Patients with solid tumors</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Oncology Letters
ISSN
1792-1074
e-ISSN
—
Volume of the periodical
14
Issue of the periodical within the volume
6
Country of publishing house
GR - GREECE
Number of pages
4
Pages from-to
7545-7548
UT code for WoS article
000417293400170
EID of the result in the Scopus database
2-s2.0-85032658340